🇺🇸 FDA
Patent

US 11419812

Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K2039/505A61K2039/542

Quick answer

US patent 11419812 (Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/505, A61K2039/542, A61K2039/545, A61K38/00